Braingaze
London, GB · 1 known investors
Braingaze develops eye-movement biomarker analysis and AI tools for the diagnosis, treatment, and monitoring of ADHD and other neurodevelopmental conditions such as autism and dyslexia. Its products are used by clinicians and therapy providers to support objective assessment and attention-training therapy for patients.
AI & Machine LearningDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Braingaze do?
- Braingaze develops eye-movement biomarker analysis and AI tools for the diagnosis, treatment, and monitoring of ADHD and other neurodevelopmental conditions such as autism and dyslexia. Its products are used by clinicians and therapy providers to support objective assessment and attention-training therapy for patients.
- Who are Braingaze's investors?
- Braingaze's investors include Capital Cell.
- Where is Braingaze headquartered?
- Braingaze is headquartered in London, GB.